The North America Nasogastric Tube Market would witness market growth of 4.6% CAGR during the forecast period (2022-2028).
The key factors driving the growth of the nasogastric tube market are the exponentially increasing geriatric population and the prevalence of chronic diseases, such as diabetes, cardiovascular diseases, cancer, respiratory diseases, and gastrointestinal diseases, which have led to an increase in patient pools. While nasogastric tubes are increasingly required in hospitals to enable enteral feeding, medicinal support, and gastric decompression, the increasing frequencies of hospitalization among juvenile and geriatric populations will provide profitable growth opportunities.
In addition, shifting trends regarding the transition from parenteral to enteral feeding and increased public awareness of enteral feeding will contribute to the market's future growth. The rise in the prevalence of chronic conditions, including cardiovascular disorders, cancer, and bleeding disorders, drives the nasogastric tube market.
The population aged 65 and older in the United States in 2019 reached 54.1 million. They comprised 16% of the population, or one out of every seven Americans. Since 2009, the number of Americans aged 65 and over has climbed by 14.4 million (36%), compared to a 3% increase in the population of those under 65. By 2060, roughly one-quarter of Americans will be 65 or older, and the number of those 85 and older will triple. The nation might experience a rise in healthcare demand due to this ageing population. In 2014, more than 6 million Canadians were 65 or older, constituting 15.6% of the country's population. In the North American market for nasogastric tubes, the escalating incidence of cancer and the ageing of the population are indicators of future growth.
The US market dominated the North America Nasogastric Tube Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $178.8 million by 2028. The Canada market is poised to grow at a CAGR of 7% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 6.1% during (2022 - 2028).
Based on Indication, the market is segmented into Dysphagia, Chronic Kidney Disease, Inflammatory Bowel Disease (IBD), Esophageal Cancer, Stomach Cancer and Others. Based on Patient Type, the market is segmented into Adult, Geriatric and Pediatric. Based on Type, the market is segmented into Small-bore Feeding Tubes and Large-bore Feeding Tubes. Based on End-Use, the market is segmented into Hospitals & Nursing Homes and Home Care. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Nasogastric Tube Market is Projected to reach USD 669.5 Million by 2028, at a CAGR of 5.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Medtronic PLC, Cardinal Health, Inc., QMD, Angiplast Pvt. Ltd., Securmed Spa, Vygon SAS, Andersen Products, Inc. (Weiler Abrasives Group), Guangdong Baihe Medical Technology Co., Ltd. and Poly Medicure Ltd.
By Indication
By Patient Type
By Type
By End-Use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 